american peptide bpc 157 BPC-157 BPC-157 - Research Grade Peptide
Description
A randomised controlled trial published in Clinical Infectious Diseases demonstrated that Thymosin Alpha-1 treatment in severe COVID-19 patients reduced 28-day mortality by 30% compared to standard care alone.17 While this was acute disease, not long COVID, it confirms the biological plausibility of the immune mechanism
They are bioidentical to the B12 forms occurring in the human body and in animal foods
Suicidal thoughts or a history of depression, as these may require close monitoring
serious adverse effects are rare
Arts J, Caenepeel P, Bisschops R, et al
